R. M. Temple

456 total citations
16 papers, 279 citations indexed

About

R. M. Temple is a scholar working on Nephrology, Pharmacology and Emergency Medicine. According to data from OpenAlex, R. M. Temple has authored 16 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Pharmacology and 5 papers in Emergency Medicine. Recurrent topics in R. M. Temple's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Dialysis and Renal Disease Management (5 papers) and Erythropoietin and Anemia Treatment (3 papers). R. M. Temple is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Dialysis and Renal Disease Management (5 papers) and Erythropoietin and Anemia Treatment (3 papers). R. M. Temple collaborates with scholars based in United Kingdom, Egypt and United States. R. M. Temple's co-authors include R.J. Winney, Thomas G. Wilson, Ian J. Deary, L. F. Prescott, Julia Critchley, Iain C. Macdougall, J.T.C. Kwan, Una Martin, Hugh C. Rayner and Mark Thomas and has published in prestigious journals such as American Journal of Kidney Diseases, Journal of Periodontology and Nephrology Dialysis Transplantation.

In The Last Decade

R. M. Temple

16 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. M. Temple United Kingdom 9 85 57 53 42 40 16 279
Jacob Sevastos Australia 6 66 0.8× 24 0.4× 52 1.0× 15 0.4× 12 308
S S Fenton Canada 9 201 2.4× 17 0.3× 19 0.4× 15 0.4× 14 331
José Abrão Cardeal da Costa Brazil 12 132 1.6× 7 0.1× 16 0.3× 2 0.0× 9 0.2× 31 304
Walter L. Bender United States 7 102 1.2× 24 0.4× 16 0.3× 18 0.5× 9 425
Walter Douthat Argentina 13 266 3.1× 7 0.1× 28 0.5× 4 0.1× 5 0.1× 54 504
Brian R. McDonald United States 9 160 1.9× 100 1.8× 12 0.2× 73 1.8× 16 420
Sophie Bouvet France 11 12 0.1× 14 0.2× 42 0.8× 1 0.0× 23 0.6× 17 404
Tom Lea‐Henry Australia 6 61 0.7× 27 0.5× 9 0.2× 26 0.7× 12 355
Alessandro Bellucci United States 13 263 3.1× 9 0.2× 44 0.8× 2 0.0× 9 0.2× 28 726
Jia-Sin Liu Taiwan 9 172 2.0× 9 0.2× 16 0.3× 2 0.0× 10 0.3× 12 395

Countries citing papers authored by R. M. Temple

Since Specialization
Citations

This map shows the geographic impact of R. M. Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. M. Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. M. Temple more than expected).

Fields of papers citing papers by R. M. Temple

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. M. Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. M. Temple. The network helps show where R. M. Temple may publish in the future.

Co-authorship network of co-authors of R. M. Temple

This figure shows the co-authorship network connecting the top 25 collaborators of R. M. Temple. A scholar is included among the top collaborators of R. M. Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. M. Temple. R. M. Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thomas, Mark, et al.. (2019). The Acute Kidney Outreach to Prevent Deterioration and Death trial: a large pilot study for a cluster-randomized trial. Nephrology Dialysis Transplantation. 36(4). 657–665. 2 indexed citations
2.
Bion, Julian, Cassie Aldridge, Alan Girling, et al.. (2017). Two-epoch cross-sectional case record review protocol comparing quality of care of hospital emergency admissions at weekends versus weekdays. BMJ Open. 7(12). e018747–e018747. 6 indexed citations
3.
Lindenmeyer, Antje, Hema Mistry, Alice Sitch, et al.. (2016). Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) trial: the protocol for a large pilot study. BMJ Open. 6(8). e012253–e012253. 7 indexed citations
4.
Rayner, Hugh C., Indranil Dasgupta, V. Suresh, et al.. (2013). Does community-wide chronic kidney disease management improve patient outcomes?. Nephrology Dialysis Transplantation. 29(3). 644–649. 24 indexed citations
5.
Ting, Stephen, et al.. (2009). Early and Late Presentations of Ethylene Glycol Poisoning. American Journal of Kidney Diseases. 53(6). 1091–1097. 24 indexed citations
7.
Rayner, Hugh C., et al.. (2002). A comparison of hospital readmission rates between two general physicians with different outpatient review practices. BMC Health Services Research. 2(1). 12–12. 12 indexed citations
8.
Martin, Una, R. M. Temple, Gopalakrishnan Venkat‐Raman, & L. F. Prescott. (2002). PHARMACOKINETICS AND DISPOSITION. 1 indexed citations
9.
Temple, R. M., Ian J. Deary, & R.J. Winney. (1995). Recombinant erythropoietin improves cognitive function in patients maintained on chronic ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation. 10(9). 1733–1738. 26 indexed citations
10.
Wilson, Thomas G., et al.. (1993). The Results of Efforts To Improve Compliance with Supportive Periodontal Treatment in a Private Practice. Journal of Periodontology. 64(4). 311–314. 56 indexed citations
11.
Martin, Una, R. M. Temple, R.J. Winney, & L. F. Prescott. (1993). The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis. European Journal of Clinical Pharmacology. 45(2). 141–145. 7 indexed citations
12.
Temple, R. M., et al.. (1992). Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrology Dialysis Transplantation. 7(3). 240–245. 21 indexed citations
13.
Jenkins, David, et al.. (1992). Effect of treatment mode on the natural history of acquired cystic disease of the kidney in patients on renal replacement therapy. Nephrology Dialysis Transplantation. 7(7). 613–617. 3 indexed citations
14.
Martin, Una, R. M. Temple, R.J. Winney, & L. F. Prescott. (1991). The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure. European Journal of Clinical Pharmacology. 41(1). 43–46. 14 indexed citations
15.
Prescott, L. F., et al.. (1989). Paracetamol disposition and metabolite kinetics in patients with chronic renal failure. European Journal of Clinical Pharmacology. 36(3). 291–297. 42 indexed citations
16.
Temple, R. M.. (1983). The end of clinical freedom. BMJ. 287(6404). 1546.4–1546. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026